UK +44 (0)1865 849841
Malaysia +60 3 2117 5193
  • The Human Microbiome – A New Frontier

    The vast majority of human-related microbiology focuses on bacteria – the human bacteriome. Frequently, the term “microbiome” is incorrectly confused with “bacteriome”. Advances in DNA sequencing and culturomics have opened the door on the human “mycobiome”, expanding interest beyond bacteria into fungal effects on multiple facets of human health.

  • 11 Ways To Enable More UK Patients To Benefit From Medicinal Cannabis

    The Drug Science Medicinal Cannabis Working Group (MCWG) and Project TWENTY21 aim to further the availability of medicinal cannabis in the UK so that the medicine can reach patients in need

  • Acrylamide, Plant Genomics And The Food Industry

    Ahead of the 8th Plant Genomics and Gene Editing Congress, we asked keynote speaker Nigel Halford, Principal Research Scientist at Rothamsted Research, UK, to share with us the background to his research…

  • The Skin Safari: Looking Back On A Decade Of Skin Microbiome Discoveries

    Dr Monty Lyman takes us on a journey through the last decade of ground-breaking skin microbiome research, and peers ahead into the next.

What does international collaboration mean for you?

The present COVID-19 crisis has demonstrated the vital need for knowledge sharing across the global science community. We asked three of our speakers what international collaboration means for them as leaders in their fields.

Read More

Cell therapies: opportunities and challenges

This article is republished with kind permission from BioVox.

Recent activities in the cell therapy field have prompted many investment funds to pour fresh and increasing capital into this space. In this review, we would like to share some observations and highlight a few of the questions that arise when new modalities cross the bridge from bench to bed.

Read More

How blockchains will transform healthcare (infographic)

Check out this guide to learn more about the potential impact of blockchains on the medical and healthcare sectors.

Read More

An Overview of Available Preclinical Models for Non-alcoholic Fatty Liver Disease

NASH is thought to affect 25% of the global population and is a primary risk factor for Hepatocellular carcinoma (HCC)  the second most common cause of cancer deaths worldwide. Understanding the aetiology of NAFLD progression, developing non-invasive diagnostic tests and developing treatments are urgent priorities.

Read More

COVID-19 and global collaboration in science

International collaboration and travel are integral to the life of researchers and biotechnology professionals. But coronavirus has made travel impossible. 

We look back over two decades of growth in international scientific collaboration to understand the extent of the effects of reduced mobility and consider what collaboration will look like in the foreseeable future.

Read More

The Biosynthesis of Cannabinoids

We recently spoke to Jeremy Friedberg, CSO of  LAVVAN, a company pioneering the biosynthesis of cannabinoids. The conversation was recorded as a podcast, which can be found here.

Read More

Digital Pathology: Lagging or Leading?

When compared to traditional methods, digital pathology may seem totally superfluous, or interesting but not all that essential. And since the costs for the elegance of digital pathology solutions are not trivial in comparison to what the peddlers traditionally have offered, it is not surprising to see the adoption curve lagging. Where then is the ‘burning platform’ that can truly drive greater adoption of digital pathology? 

Read More

Understanding the gut-liver axis: implications for NAFLD prevention and treatment

You may have heard; humans are superorganisms. The human large intestine harbors tens of trillions of microbes, which equates to roughly 2 kg of cells. For reference, that’s how much your brain weighs! Within the gut microbiome, it is estimated that there are over 1,000 different species of bacteria.

Read More

What does international collaboration mean for you?

The present COVID-19 crisis has demonstrated the vital need for knowledge sharing across the global science community. We asked three of our speakers what international collaboration means for them as leaders in their fields.

Read More

Cell therapies: opportunities and challenges

This article is republished with kind permission from BioVox.

Recent activities in the cell therapy field have prompted many investment funds to pour fresh and increasing capital into this space. In this review, we would like to share some observations and highlight a few of the questions that arise when new modalities cross the bridge from bench to bed.

Read More

How blockchains will transform healthcare (infographic)

Check out this guide to learn more about the potential impact of blockchains on the medical and healthcare sectors.

Read More

An Overview of Available Preclinical Models for Non-alcoholic Fatty Liver Disease

NASH is thought to affect 25% of the global population and is a primary risk factor for Hepatocellular carcinoma (HCC)  the second most common cause of cancer deaths worldwide. Understanding the aetiology of NAFLD progression, developing non-invasive diagnostic tests and developing treatments are urgent priorities.

Read More

COVID-19 and global collaboration in science

International collaboration and travel are integral to the life of researchers and biotechnology professionals. But coronavirus has made travel impossible. 

We look back over two decades of growth in international scientific collaboration to understand the extent of the effects of reduced mobility and consider what collaboration will look like in the foreseeable future.

Read More

Digital Pathology: Lagging or Leading?

When compared to traditional methods, digital pathology may seem totally superfluous, or interesting but not all that essential. And since the costs for the elegance of digital pathology solutions are not trivial in comparison to what the peddlers traditionally have offered, it is not surprising to see the adoption curve lagging. Where then is the ‘burning platform’ that can truly drive greater adoption of digital pathology? 

Read More

Understanding the gut-liver axis: implications for NAFLD prevention and treatment

You may have heard; humans are superorganisms. The human large intestine harbors tens of trillions of microbes, which equates to roughly 2 kg of cells. For reference, that’s how much your brain weighs! Within the gut microbiome, it is estimated that there are over 1,000 different species of bacteria.

Read More

Automatic AI-powered Tumor Budding

Tumor Budding has been shown in numerous studies to be an independent prognostic factor in colorectal cancer (CRC) for the risk of distant metastasis and, in stage II CRC, for overall survival. Fraunhofer IIS and the Institute for Pathology, University Hospital Erlangen are developing an AI system to automatically detect tumor budding in CRC patients.

Read More

What does international collaboration mean for you?

The present COVID-19 crisis has demonstrated the vital need for knowledge sharing across the global science community. We asked three of our speakers what international collaboration means for them as leaders in their fields.

Read More

The Biosynthesis of Cannabinoids

We recently spoke to Jeremy Friedberg, CSO of  LAVVAN, a company pioneering the biosynthesis of cannabinoids. The conversation was recorded as a podcast, which can be found here.

Read More

The grass has never been greener for engineering plant immunity and resilience

Scientific research is always working at the frontiers of knowledge, but plant genomics technologies have had a dramatic impact on plant science even by our standards. The wide availability of sequencing technologies has been a rare step-change that has unlocked knowledge in a way nobody in the field could have imagined twenty years ago. Knowledge which could make a considerable contribution to food security in the face of changing climates.

Read More

New Breeding Techniques: cloning major resistance genes in cereals

Advances in breeding techniques for cereal crops will be a focus at the 8th Plant Genomics and Gene Editing Congress: USA. We asked Burleigh Dodds, an agricultural science publisher, to share an extract from one of their recent publications, ‘Advances in breeding techniques for cereal crops’.

Read More

Plant biotech in Europe: Present and future

Marcel Kuntz is a panellist for the panel discussion on the regulatory landscape for plant biotechnology at the 8th Plant Genomics & Gene Editing Congress: Europe. Here he provides us with some background for the discussion.

Read More

Using genome editing technology within a systems biology approach to understand plant immunity

Interested in systems biology, omics technology, and plant bioinformatics? Catch up with one of our speakers from the 8th Plant Genomics and Gene Editing Congress: Europe, Professor Kristina Gruden…

Read More

The case for biosynthesis: 5 problems with cannabinoids derived from plant cultivation

As we look at the current and future market demands for cannabinoid ingredients, large consumer buyers are focused on purity, consistency and stability of supply. For a host of reasons, cannabinoid suppliers will find it extraordinarily difficult to meet this demand with plant-based production systems.

Read More

Wild wheat, plant genomics, and food security

Wheat is the most widely grown crop in the world, providing 20% of the calories and proteins consumed by humankind. More than one fifth of the projected yield is lost every year to disease. Dr Brande Wulff, Group Leader at the John Innes Centre, and speaker at the 8th Plant Genomics and Gene Editing Congress, Europe, is leading research aiming to reduce the proportion of wheat lost to pathogens and increase global food security…

Read More

Examining Blockchain Systems & Designing Smart Contracts

The blockchain has the potential to enable the collaboration between patients, researchers, and care providers to provide individualised care for patients, but how can this technology be harnessed in a practical way?

This was one of the key questions that was asked at the Blockchain in Healthcare Congress and we had the pleasure of welcoming an array of expert speakers from pharma, academia, and industry to provide the answer.

Read More

The role of extrinsic motivation in sports and physical activity

Motivation is one of the most significant psychological concepts in many areas of life – from work and education to achieving personal goals. In sports and physical activity, motivation plays an especially important part due to the fact that, to millions of people worldwide, staying fit and active is not an obligation or a professional prerequisite, but rather a personal goal. Blockchain technology, together with elements of gamification, may actually help people achieve this goal.

Read More

Conciliating Blockchain and GDPR

Aurélie Bayle is a Data Protection Officer at be-ys: a role she considers to be at the heart of the new legal framework for any company.

Before GDPR came into effect on 25th May 2018, she was working towards global compliance, which involved completing all the steps given by the Article 29 Data Protection Working Party, an advisory board made up of a representative from the data authority of each EU Member State, the European Data Protection Supervisor, and the European Commission. Her duties have included auditing the structures and processes, preparing the data protection impact assessments, checking the compliance of processing activities, analysing the risks of the processing in the medical area, preparing new processes and policies about data protection, and asking data processors about their own compliance.

Read More

When Blockchain Meets the Right to be Forgotten: Technology Versus Law

Over the past few years, the popularity of the blockchain and cryptocurrencies has increased and has reached important notoriety, not only in scientific and IT journals, but also in the media. Although there are many kinds of cryptocurrencies in circulation nowadays, the most popular is Bitcoin.

Read More

Supporting Blockchain Startups: An Open Letter from Katherine Merton

Dear colleagues,

The blockchain technology market is expected to grow to 2.3 billion US dollars by 2021, from 339.5 million US dollars in 2017. [1] With an annual growth rate of 61.5%, it is one of the fastest growing technologies in the healthcare industry.

Read More

The Big List of Microfluidics Companies & Investors

The microfluidic-based devices market has been growing since 2014 due to the increasing point of care testing demand and the miniaturisation of microfluidic chips. 

Read More

What will we do with all this data?

The amount of data we are creating every day has increased exponentially to match the rise in use of smart and connected devices. The internet of things has connected every aspect of our lives to the digital realm: most of these devices operate by tracking your habits, movements, preferences, voice, and more, then logging those habits online. Specifically, the collection of health data has become abundant, because most people now have or wear some sort of device to track daily patterns, steps, cycles, and more. Even our phones often default to track these things for us, whether we choose to enable the function or not.

Read More

How Standards & Standardised Infrastructure Fuel Innovation

It might surprise a lot of people to learn that standards can be viewed as a tool to support innovation, to set businesses free and to focus on the core of their product where their expertise lie. When working with the use of electronic communication systems within the entire healthcare sector, the main focal point is often ensuring a good support for collaboration and work processes.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive